Deepro R. Mukerjee is the national co-chair of Katten's Patent Litigation practice and is a member of the firm’s Board of Directors. He represents the world's largest generic pharmaceutical companies in Hatch-Waxman cases throughout the country. His work on these critical cases is part of a larger practice advising numerous multi-national companies (pharmaceutical and otherwise) on their respective IP needs – particularly when it comes to "bet the company" litigations. Deepro is a first chair litigator, and has tried bench and jury trials across the country.
Hatch-Waxman litigation and more
Deepro has been lead trial counsel in dozens of Hatch-Waxman cases, often taking them to trial and subsequent appeals. He is also experienced at handling inter partesreview proceedings before the Patent Trial and Appeal Board. While his focus is in the pharmaceutical and life sciences arena, Deepro's litigation experience is more expansive and covers matters related to biotechnology, botanicals, electrical circuit interrupting devices and voice recognition software.
In addition to his substantial litigation experience, Deepro often provides patent-centric due diligence and other intellectual property counsel to multinational clients in connection with transactions such as public offerings and venture capital financings. He also advises companies on how to best leverage their IP portfolios in connection with spin outs and exit strategies. A recognized industry leader, Deepro had been named to the IAM 1000 leading world-wide patent practioners list for 5 years in a row and was recently designated an "IP Star" by Managing Intellectual Property.
